由于不遵守监管规定,IMAC控股公司可能面临从Nasdaq公司除名的风险。 IMAC Holdings faces potential delisting from Nasdaq due to regulatory compliance failures.

以田纳西州为基地的一家医疗公司IMAC控股公司收到Nasdaq因不符合上市规则而发出的通知,包括延迟提交季度报告。 IMAC Holdings, a Tennessee-based medical company, received notices from Nasdaq for failing to meet listing rules, including a delayed quarterly report filing. 该公司必须提交一份计划,以便在2024年1月21日前恢复遵守,并可能延长到180天。 The company must submit a plan to regain compliance by January 21, 2024, with possible extensions up to 180 days. IMAC 正在努力纠正这些问题并避免除名。 IMAC is working to rectify the issues and avoid delisting.